US Court Invalidates Sanofi’s Taxotere Patents

Two Sanofi-Aventis SA patents on the cancer drug Taxotere were invalidated by a U.S. court on Monday, clearing the way for Hospira Inc to launch a generic version by the end of the year.
CNBC